There are only a few months left until an annual highlight in our CML meeting calendar. And this time we are meeting in person again! You can now register for the 24th Annual John Goldman Conference on CML that will take place in Mandelieu La-Napoule in France from October 21-23, 2022. Once again, you can expect a comprehensive scientific programme with many highlights from the biology and therapy of CML. Learn more... Generic therapie Transplant and Comorbidities - New Topics in the iCMLf Knowledge Centre
Module 5 is a series of highly practical talks on the practical management of CML to help you in your clinical practice. We are pleased to announce that a second set of presentations is now available to view. New topics include; generics, the role of allograft in the era of TKIs and two more presentations on managing comorbidities, tuberculosis and ophthalmologic manifestations as the initiation presentation of CML. CML Highlights of EHA 2022 on July 14th at 2 pm CESTJune 2022 - Following our series of updates on CML and COVID-19 in non-English languages, the next highlight in our series of iCMLf Conversations is coming up soon. CML Highlights of EHA 2022 – Biological and clinical overviewJoin us to discuss CML highlights from the recent EHA 2022 Hybrid Congress during an expert talk on Thursday, July 14th at 2 pm Central European Summer Time. Don’t miss this opportunity and join us for the live webinar. Update on COVID-19 and CML in Spanish on June 21st at 10.00 Argentina Time / 15.00 CEST
iCMLf Conversation on CML: Update on COVID-19 and CML – in Spanish on June 21, 2022 at 10.00 Argentina Time
Dra Carolina Pavlovsky / Dra Beatriz Moiraghi Catch up with the iCMLf in our June 2022 NewsletterJune 2022 - It’s our pleasure to bring you the latest iCMLf Newsletter for June 2022. Read about our most recent achievements, including those in our Global Alliances. Contents Overview:
iCMLf COVID-19 Hub - Updated statement on COVID-19 vaccines for people with CML
Questions about CML management during the COVID-19 pandemic remain highly relevant for clinical practice. In particular, whether COVID-19 vaccines are recommended and effective for people with CML. To provide you with the best possible support, the iCMLf continues to update our COVID-19 Hub with CML specific information on COVID-19. We are also sharing an updated statement on COVID-19 vaccines for people with CML. You can read the full statement below: Our Board of Directors |